PULMONARY VASCULAR RESEARCH INSTITUTE
We are a global family | The Pulmonary Vascular Research Institute (PVRI)
1127115
2008
SE1 3LE
pvrinstitute.org
PVRI
Podobné organizace
Podobné organizace global
Podobně sociální sítě (2351)
Business Academy, z.s.2395 |
|
Volejbal Ústí nad Labem, z.s.2368 |
|
International Police Association - sekce Česká republika z.s.2391 |
|
TOPAZ, z.s.2386 |
|
SK VOLEJBAL Ústí nad Labem, z.s.2368 |
Novinky
RT @EuropePHA: 📣 PHAEUROPE invites you to a free, patient-focused webinar unpacking key findings from the Pulmonary Hypertension Global Pat… (tw)
📢 From Patient Voices to Action: Understanding the PH Global Survey - A Webinar for Patients and Carers on PHGPS European Findings 📅 Friday, 29 August | 🕚 11:00 BST | 💻 Online via Zoom We’re excited to invite you to a free, patient-focused webinar that unpacks key findings https://t.co/P8qFm5Nx75 (tw)
Poslední komentáře
So excited for PVRI 2026 in Dublin! 🌍 Can't wait to connect with like-minded professionals and contribute to a world free of pulmonary vascular diseases!detail |
|
Thrilled to see the focus on inclusivity and innovation at this year's symposium! Together, we can make a difference in the lives of those affected by pulmonary hypertension! 💙detail |
Poslední diskuze
1. How can we enhance global collaboration among professionals in the field of pulmonary vascular diseases to accelerate drug development and improve patient care?Odpovědí: 3, Naposledy před 1 den detail |
|
2. What innovative strategies can be implemented to ensure diversity and inclusion in clinical trials for pulmonary arterial hypertension (PAH) therapies?Odpovědí: 3, Naposledy před 1 den detail |
V okolí
4.5
SE1 3LE
O společnosti
- G58, E05, H12, H40 -
User account menu Main navigation User account menu We are a global family We are pulmonary hypertension professionals united in our vision for a world without pulmonary vascular disease. We believe we can achieve this together and we wont stop until we do. Full scientific programme is live. With the theme of Inclusive and sustainable drug development for PAH the programme is divided into 6 sessions new standards of care disease modification diversity and inclusion global aspects of drug development and availability innovations in trial design and novel drug device therapies.
Výzkumná ústavy a/nebo analýza veřejné politiky Shromažďování finančních prostředků a/nebo distribuce finančních prostředků. Konkrétní výzkum orgánů
